The found that the S15A, R145A or N175A mutants showed markedly reduced activity, whereas the K14A mutation completely abolished activity, and deletion of residues 27-101 (Δ27-101) led to a significant loss of function.
Abstract
Tuberculosis (TB) continues to represent a significant global health danger, with the bacillus Mycobacterium tuberculosis (Mtb) identified as its causative agent. An essential metabolic helper, Coenzyme A (CoA) engages in multiple core cellular processes that are pivotal for both Mtb survival and its ability to cause disease. The terminal step of CoA biosynthesis is catalyzed by dephospho-CoA kinase CoaE, which phosphorylates dephospho-CoA to generate the active cofactor. However, the molecular mechanisms regulating Mtb CoaE catalytic activity remain poorly understood. Here, AlphaFold 3 was used to predict CoaE model. The Ramachandran plot and ProSA were used to validate the model. Subsequently, we performed molecular docking, followed by site-directed mutagenesis. We found that the S15A, R145A or N175A mutants showed markedly reduced activity, whereas the K14A mutation completely abolished activity. Additionally, deletion of residues 27-101 (Δ27-101) led to a significant loss of function. Our findings offer new insights into the structure and mechanism of Mtb CoaE, a promising target for designing selective antituberculosis agents.
These findings provide a mechanistic rationale for MtbCBS inhibition, and the unexplored roles of these key residues can be considered in the design of next-generation inhibitors targeting CBS enzymes implicated in infectious diseases, cancer, and neurological disorders.
Sainath Polepalli, Anupam Roy, Bapan Mondal et al.· International Journal of Bio...· 0 citations
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health concern, particularly due to the emergence of drug-resistant strains. FAD-containing monooxygenase EthA activates the antitubercular prodrug ethionamide (ETH) in Mtb. However, the structural and functional mechanisms of Mtb Eth...
These findings establish BVL3572S as a promising lead compound acting through a previously unexploited, multitarget mechanism, and display strong synergy with the antitubercular drug D-cycloserine.
Zainab Edoo, Astrid Lenne-Delmotte, C. Grosse et al.· Cell Chemical Biology· 0 citations
ABSTRACT Mycobacterium tuberculosis (Mtb) causes over 1 million deaths from tuberculosis (TB) every year and remains a major burden on human health. Reducing the deadly impact of TB requires a better understanding of the strategies used by M. tuberculosis to adapt its metabolism, survive, and persist in the human host....
Yi Liu, Nadine Ruecker, Valwynne Faulkner et al.· Journal of Bacteriology· 0 citations
A new series of phthalimide derivatives was synthesized and structurally characterized through 1H NMR and 13C NMR, with further optimization performed at the DFT level, identifying C15 and C17 as promising lead compounds for further optimization as multitarget enzyme inhibitors.
A. Khushal, Sara Khan, Umar Farooq et al.· Bioorganic chemistry (Print)· 0 citations
Human-adapted Mycobacterium tuberculosis (Mtb) also infects animals and transmits zoonotically, threatening public health. The cell wall glycolipids lipoarabinomannan and lipomannan are essential virulence factors of Mtb. Phosphatidyl-myo-inositol mannosyltransferase PimA catalyzes a key step in their biosynthesis and...
Da-Feng Liu, Hua-Shui Deng, Xinbao Liu et al.· Frontiers in Cellular and In...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.